IRMD
Iradimed Co
NASDAQ: IRMD · HEALTHCARE · MEDICAL DEVICES
$84.32
-0.53% today
Updated 2026-06-05
Market cap
$1.18B
P/E ratio
50.30
P/S ratio
13.33x
EPS (TTM)
$1.83
Dividend yield
0.82%
52W range
$54 – $107
Volume
0.1M
Iradimed Co (IRMD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$84.32
12-Month target
$65.52
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 27.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.